We found that IL-2Jc administered on the day of infection resulted in lower serum IFNγ levels by day 4 p.i., whereas neither IL-2Sc nor delayed IL-2Jc treatment had any significant effect (Figure S2). The gene discussed is IFNG; the disease is infection.